JSM Preliminary Online Program
This is the preliminary program for the 2008 Joint Statistical Meetings in Denver, Colorado.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2008 Program page




Activity Number: 215
Type: Invited
Date/Time: Tuesday, August 5, 2008 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract - #300345
Title: Regulatory Perspectives on Planning for Pre-Marketing
Author(s): George Rochester*+
Companies: U.S. Food and Drug Administration
Address: 10903 New Hampshire Ave, Silver Spring, MD, 20993,
Keywords: risk ; safety ; safety analysis plan ; risk identification model
Abstract:

In the current climate of heightened expectation from consumers, legislative bodies and other stakeholders, there is a need to improve pre-marketing risk assessment. Risk evaluation must be systematically considered throughout the lifecycle of a product. This presentation will discuss two new ideas. The first is the Pre-approval Risk Identification Model (PRIM), which aims to streamline safety evaluation throughout the life-cycle to meet regulatory requirements for good safety assessment which forms the basis for good risk management. The second is the Safety Analysis Plan, presented as a tool for documenting the risk identification processes and analytical framework for regulatory submissions, data analysis and presentation. A case study will be presented.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2008 program


JSM 2008 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised September, 2008